Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.70 is 110% above its 5-year average of 2.71, near the high end of its 5-year range (0.11–6.66).
As of the fiscal period ended Tuesday, June 30, 2026. 5.22% above its 12-month average of 5.41.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.70.
QUICK RATIO (ACID-TEST)
5.70
QUICK RATIO (ACID-TEST) AVG TTM
5.41
QUICK RATIO (ACID-TEST) AVG 3Y
3.85
QUICK RATIO (ACID-TEST) AVG 5Y
2.71
QUICK RATIO (ACID-TEST) AVG 10Y
3.46
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.22%
CURRENT VS 3Y AVG
+48.03%
CURRENT VS 5Y AVG
+110.02%
CURRENT VS 10Y AVG
+64.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+70.03%
vs the sector median at left
ImmunityBio, Inc.
Market Cap
$10.30B
Quick Ratio (Acid-Test)
5.70
TTM Avg
5.41
3Y Avg
3.85
5Y Avg
2.71
Market Cap
$10.33B
Quick Ratio (Acid-Test)
2.93
TTM Avg
2.25
3Y Avg
2.88
5Y Avg
3.49
Market Cap
$10.21B
Quick Ratio (Acid-Test)
1.68
TTM Avg
1.66
3Y Avg
1.58
5Y Avg
1.56
Market Cap
$10.21B
Quick Ratio (Acid-Test)
1.28
TTM Avg
1.17
3Y Avg
1.11
5Y Avg
1.16
Market Cap
$10.19B
Quick Ratio (Acid-Test)
5.25
TTM Avg
4.17
3Y Avg
4.17
5Y Avg
4.87
Market Cap
$10.55B
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.94
3Y Avg
4.84
5Y Avg
6.08
Market Cap
$10.03B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.49
3Y Avg
1.44
5Y Avg
1.33
Market Cap
$9.97B
Quick Ratio (Acid-Test)
7.64
TTM Avg
7.20
3Y Avg
5.45
5Y Avg
4.39
Market Cap
$9.94B
Quick Ratio (Acid-Test)
2.33
TTM Avg
4.52
3Y Avg
4.42
5Y Avg
3.69
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.30B | 5.70 | 5.41 | 3.85 | 2.71 |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 2.93 | 2.25 | 2.88 | 3.49 |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 1.68 | 1.66 | 1.58 | 1.56 |
| Align Technology, Inc. (ALGN)vs › | $10.21B | 1.28 | 1.17 | 1.11 | 1.16 |
| 10x Genomics, Inc. (TXG)vs › | $10.19B | 5.25 | 4.17 | 4.17 | 4.87 |
| Twist Bioscience Corporation (TWST)vs › | $10.55B | 2.38 | 3.94 | 4.84 | 6.08 |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 1.21 | 1.49 | 1.44 | 1.33 |
| Repligen Corporation (RGEN)vs › | $9.97B | 7.64 | 7.20 | 5.45 | 4.39 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.94B | 2.33 | 4.52 | 4.42 | 3.69 |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 1.04 | 1.07 | 1.16 | 1.16 |
Quick Ratio
5.70
Excludes inventory
Current Ratio
5.72
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.70 |
| 2026-03-31 | 6.66 |
| 2025-12-31 | 5.08 |
| 2025-09-30 | 5.65 |
| 2025-06-30 | 3.98 |
| 2025-03-31 | 2.05 |
| 2024-12-31 | 3.21 |
| 2024-09-30 | 2.64 |
| 2024-06-30 | 3.88 |
| 2024-03-31 | 3.64 |
| 2023-12-31 | 5.05 |
| 2023-09-30 | 2.38 |
| 2023-06-30 | 0.11 |
| 2023-03-31 | 0.20 |
| 2022-12-31 | 0.28 |
| 2022-09-30 | 1.74 |
| 2022-06-30 | 0.31 |
| 2022-03-31 | 0.53 |
| 2021-12-31 | 0.91 |
| 2021-09-30 | 1.44 |
| 2021-06-30 | 1.53 |
| 2021-03-31 | 1.25 |
| 2020-12-31 | 1.64 |
| 2020-09-30 | 1.45 |
| 2020-06-30 | 6.76 |
| 2020-03-31 | 3.10 |
| 2019-12-31 | 4.82 |
| 2019-09-30 | 5.72 |
| 2019-06-30 | 7.00 |
| 2019-03-31 | 4.09 |
| 2018-12-31 | 3.26 |
| 2018-09-30 | 3.31 |
| 2018-06-30 | 5.45 |
| 2018-03-31 | 6.54 |
| 2017-12-31 | 6.35 |
| 2017-09-30 | 5.47 |
| 2017-06-30 | 4.92 |
| 2017-03-31 | 13.80 |
| 2016-12-31 | 16.34 |
| 2016-09-30 | 20.96 |
| 2016-06-30 | 21.70 |
| 2016-03-31 | 28.70 |
| 2015-12-31 | 48.40 |
| 2015-09-30 | 53.91 |
| 2015-06-30 | 20.01 |
| 2015-03-31 | 16.35 |
| 2014-12-31 | 24.69 |
